Core Insights - Bayer's Health Consumer Division showcased five "global first" innovative products at the 8th China International Import Expo, emphasizing its commitment to providing comprehensive health solutions throughout consumers' life cycles [1][6][11] - The company views the expo as a vital platform for connecting the Chinese market with global resources, reflecting confidence in China's supply chain and innovation potential [4][23] Product Innovations - Bayer's new products address specific health management needs, including a B5 cream for diaper rash, a nasal spray for allergic rhinitis, a lactulose solution for constipation, high-purity EPA fish oil for cardiovascular health, and a calcium supplement for children [9][10][19] - The B5 cream is designed for sensitive skin, providing 16 hours of protection, while the nasal spray is recommended for children and adults [9][10] Strategic Collaborations - Bayer is deepening local collaborations through its China Innovation Cooperation Center (CCIP), focusing on "产学研" (industry-academia-research) partnerships to enhance health accessibility [13][17] - Strategic agreements were signed with local partners, including Shanghai Tianwu Technology for AI applications in health management and Shandong Jingwei Pharmaceutical for self-care solutions [15][17] Health Education Initiatives - Bayer hosted various health education activities at the expo, including forums on AI in health management and lectures on allergy prevention and digestive health [19][21] - The company aims to enhance public understanding of health issues through these initiatives, addressing consumer pain points in allergy treatment and digestive health [21][23] Global Innovation Strategy - Bayer positions the expo as a strategic anchor for its operations in China, linking local insights with global research and development [23] - The company is expanding its product offerings from local markets to international ones, exemplified by its collaboration with Xianle Health to reach broader markets [23]